Cryptogenic cirrhosis in the region where obesity is not prevalent

被引:21
作者
Kojima, Hideyuki
Sakurai, Shinya
Matsumura, Masahiko
Umemoto, Norie
Uemura, Masahito
Morimoto, Hiroyo
Tamagawa, Yasuhiro
Fukui, Hiroshi
机构
[1] Nara Med Univ, Dept Internal Med 3, Nara 6348522, Japan
[2] Nara Med Univ, Dept Gen Med & Clin Invest, Nara 6348522, Japan
[3] Kokuho Cent Hosp, Dept Internal Med, Nara 6360302, Japan
关键词
cryptogenic cirrhosis; viral cirrhosis; nonalcoholic steatohepatitis; hepatocellular carcinoma; case-control study;
D O I
10.3748/wjg.v12.i13.2080
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: Recent studies have demonstrated that obesity is the common feature of cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis. However, there is little information on CC in the region where obesity is not prevalent. METHODS: The clinical features, and the liver-related morbidity and mortality of CC were analyzed in Japan where the prevalence of obesity is low. Among 652 cirrhotic patients, we identified 29 patients (4.4%) with CC. Of these, 24 CC patients who were followed up for more than 6 months were compared in a case-control study with age-, sex-, and Child-Pugh score-matched controls having cirrhosis of viral etiology. RESULTS: Obesity (BMI >= 25 kg/m(2)), diabetes mellitus, and hypertriglyceridemia were more frequent, and the visceral fat area was larger in the CC patients than in the controls. The indices of insulin resistance were higher and the serum aminotransferase levels were lower in the CC patients than in the controls. Logistic regression analysis identified the elevated hemoglobin A1c, BMI >= 25 kg/m(2), and normal aminotransferase levels as independent predictors of CC. Kaplan-Meier analysis demonstrated lower occurrence of hepatocellular carcinoma and higher survival rate in the CC than in the controls in contrast to the similar cumulative probability of liver-related morbidity between those groups. CONCLUSION: CC more frequently presents with the clinical features suggestive of non-alcoholic steatohepatitis compared with controls even in the region where obesity is not prevalent. The lower occurrence of hepatocellular carcinoma and higher survival rate may indicate an indolent clinical course in CC as compared with viral cirrhosis. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:2080 / 2085
页数:6
相关论文
共 25 条
[1]   Cryptogenic cirrhosis: Clinicopathologic findings at and after liver transplantation [J].
Ayata, G ;
Gordon, FD ;
Lewis, D ;
Pomfret, E ;
Pomposelli, JJ ;
Jenkins, RL ;
Khettry, U .
HUMAN PATHOLOGY, 2002, 33 (11) :1098-1104
[2]   Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma [J].
Bugianesi, E ;
Leone, N ;
Vanni, E ;
Marchesini, G ;
Brunello, F ;
Carucci, P ;
Musso, A ;
De Paolis, P ;
Capussotti, L ;
Salizzoni, M ;
Rizzetto, M .
GASTROENTEROLOGY, 2002, 123 (01) :134-140
[3]   Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease [J].
Caldwell, SH ;
Oelsner, DH ;
Iezzoni, JC ;
Hespenheide, EE ;
Battle, EH ;
Driscoll, CJ .
HEPATOLOGY, 1999, 29 (03) :664-669
[4]   Liver damage in obese patients [J].
Del Gaudio, A ;
Boschi, L ;
Del Gaudio, GA ;
Mastrangelo, L ;
Munari, D .
OBESITY SURGERY, 2002, 12 (06) :802-804
[5]   Natural history of nonalcoholic steatohepatitis:: A longitudinal study of repeat liver biopsies [J].
Fassio, E ;
Alvarez, E ;
Domínguez, N ;
Landeira, G ;
Longo, C .
HEPATOLOGY, 2004, 40 (04) :820-826
[6]  
FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1
[7]   Prevalence and trends in obesity among US adults, 1999-2000 [J].
Flegal, KM ;
Carroll, MD ;
Ogden, CL ;
Johnson, CL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (14) :1723-1727
[8]   CONTRIBUTION OF INTRAABDOMINAL FAT ACCUMULATION TO THE IMPAIRMENT OF GLUCOSE AND LIPID-METABOLISM IN HUMAN OBESITY [J].
FUJIOKA, S ;
MATSUZAWA, Y ;
TOKUNAGA, K ;
TARUI, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (01) :54-59
[9]   CIRRHOSIS OF UNDEFINED PATHOGENESIS - ABSENCE OF EVIDENCE FOR UNKNOWN VIRUSES OR AUTOIMMUNE PROCESSES [J].
GREEVE, M ;
FERRELL, L ;
KIM, M ;
COMBS, C ;
ROBERTS, J ;
ASCHER, N ;
WRIGHT, TL .
HEPATOLOGY, 1993, 17 (04) :593-598
[10]   Beyond insulin resistance in NASH:: TNF-α or adiponectin? [J].
Hui, JM ;
Hodge, A ;
Farrell, GC ;
Kench, JG ;
Kriketos, A ;
George, J .
HEPATOLOGY, 2004, 40 (01) :46-54